Elmwood Wealth Management’s Xenon Pharmaceuticals XENE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$339K	Sell	10,824 -183	-2%	-$5.73K	0.13%	106
2025 Q1	$369K	Hold	11,007	–	–	0.15%	105
2024 Q4	$431K	Buy	11,007 +3,400	+45%	+$133K	0.17%	102
2024 Q3	$299K	Sell	7,607 -336	-4%	-$13.2K	0.12%	117
2024 Q2	$310K	Hold	7,943	–	–	0.14%	105
2024 Q1	$342K	Sell	7,943 -2,126	-21%	-$91.5K	0.15%	104
2023 Q4	$464K	Hold	10,069	–	–	0.33%	75
2023 Q3	$344K	Hold	10,069	–	–	0.17%	102
2023 Q2	$388K	Sell	10,069 -4,925	-33%	-$190K	0.18%	95
2023 Q1	$537K	Hold	14,994	–	–	0.25%	91
2022 Q4	$591K	Hold	14,994	–	–	0.3%	91
2022 Q3	$541K	Hold	14,994	–	–	0.27%	87
2022 Q2	$456K	Hold	14,994	–	–	0.26%	88
2022 Q1	$458K	Sell	14,994 -3,086	-17%	-$94.3K	0.23%	88
2021 Q4	$565K	Buy	+18,080	New	+$565K	0.27%	87
2021 Q2	$349K	Hold	18,729	–	–	0.18%	89
2021 Q1	$335K	Buy	+18,729	New	+$335K	0.2%	87
2020 Q3	$235K	Hold	18,729	–	–	0.19%	82
2020 Q2	$235K	Hold	18,729	–	–	0.19%	82
2020 Q1	$91.8K	Hold	18,729	–	–	0.09%	107
2019 Q4	$246K	Hold	18,729	–	–	0.21%	82
2019 Q3	$169K	Hold	18,729	–	–	0.17%	81
2019 Q2	$185K	Hold	18,729	–	–	0.16%	85
2019 Q1	$190K	Hold	18,729	–	–	0.18%	86
2018 Q4	$118K	Hold	18,729	–	–	0.11%	101
2018 Q3	$247K	Sell	18,729 -18,729	-50%	-$247K	0.21%	84
2018 Q2	$264K	Buy	37,458 +18,729	+100%	+$132K	0.24%	83
2018 Q1	$91.8K	Buy	+18,729	New	+$91.8K	0.09%	107